The Center for Continuing Medical Education (CCME)
  1. Home
  2. Webcasts
  3. Sexually Transmitted Diseases

Sexually Transmitted Diseases

January 13th, 2012 - January 13th, 2015
1.00 AMA PRA Category 1 Credit Hours

Description

Today on MedNet, we'll learn how to recognize and treat sexually transmitted diseases. It has been estimated that your patients are more likely to acquire a sexually transmitted disease this year than they are to develop breast cancer, colon cancer, lung cancer, and prostate cancer combined. But these diseases do not get the kind of press that other diseases get. They just don’t make for polite public discussion. But as health care providers, we still need to know all about these infections.
The webcast is no longer available.
Post-Test taking for this webcast is no longer available.

Dates and Times

End Date: 1/13/2015

Objectives

As a result of this educational activity, webcast participants will be able to: RECOGNIZE current epidemiologic trends of common STIs and screening recommendations from the US Centers for Disease Control and Prevention (CDC); DESCRIBE common presentations, available diagnostic modalities, and recommended treatment regiments for common STIs.

Webcasts Files

File Link

Sexually Transmitted Diseases Final - 2

 Download

Sexually Transmitted Diseases Final - 4

 Download

Speakers

  • Dr. James Allen, MD
    • Sexually Transmitted Diseases
  • Dr. Jose A Bazan, DO
    • Sexually Transmitted Diseases
  • Ph.D. Abigail Norris Turner, PhD
    • Sexually Transmitted Diseases

Accreditation

The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians

The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.